DISHMAN

DISHMAN: Members of the Exchange are hereby informed that the trading in Equity Shares of Dishman Pharmaceuticals and Chemicals Limited shall be suspended w.e.f. May 30, 2017 (i.e. closing hours of trading on May 29, 2017) on account of Scheme of Amalgamation of Dishman Pharmaceuticals and Chemicals Limited with Carbogen Amcis (India) Limited.

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "US FDA Approves Zejula Capsules.". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has submitted their response.

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "US FDA Approves Zejula Capsules.". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

DISHMAN:The Exchange had sought clarification from the Company with respect to announcement dated May 19, 2016, regarding Outcome of Board Meeting held on May 19, 2016.The reply of the Company is attached.

DISHMAN:The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to announcement dated 19-May-2016, regarding " Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2016."On basis of above the Company is required to clarify following:1. The amount and percentage of the turnover or revenue or income and net worth contributed by such subsidiary of the listed entity during the last financial year;2. Date on which the agreement for sale has been entered into;3. The expected date of co

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "USFDA gives Warning Letter to Dishman due to Clovis issues." The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has submitted their response.

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited, with respect to recent news item captioned "USFDA gives Warning Letter to Dishman due to Clovis issues". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

Dishman Pharmaceuticals and Chemicals Limited has informed the Exchange vide letter dated January 19, 2015 regarding news clarification.

The Exchange had sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to a news item captioned "Dishman Pharma in talks with investor to sell land in Gujarat". The company has clarified that "Dishman Pharmaceuticals and Chemicals Limited (DPCL) had acquired on a long term lease basis Land located at the Pharma and Finechem SEZ being developed by Dishman Infrastructure Limited (DIL), a company promoted by the promoters of DPCL. However, owing to withdrawal of the benefits granted earlier to SEZ developers/units located there in by the Government, the said company

The Exchange has sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to recent news item captioned "Dishman Pharma in talks with investor to sell land in Gujarat". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Wheth

The Exchange had sought clarification from Dishman Pharmaceuticals and Chemicals Limited with respect to a news item captioned "Dishman plans to sell Gujarat land to Nirma, exit SEZ biz". The Company has clarified that "This is a market rumor and there is no truth in the said news. None of the Company's officials have given this information to media. In fact the said SEZ land is owned by the Group company Dishman Infrastructure Ltd. and has nothing to do with Dishman Pharmaceuticals and Chemicals Limited. The Company also does not envisage Sale of the China facility".

Spurt in Volume : Substantial increase in trading volumes have been observed in Dishman Pharmaceuticals and Chemicals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dishman Pharmaceuticals and Chemicals Limited has vide its letter inter-alia stated, "We would like to state that to the best of our knowledge and belief, there is no price sensitive information / development which can have a bearing on the performances of the

News Verification : The media had reports on May 15, 2006 that Dishman Pharmaceuticals and Chemicals Limited is closer to formalising an acquisition in Switzerland. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Dishman Pharmaceuticals and Chemicals Limited has vide its letter inter-alia stated, "As a matter of strategy, the Company has been looking at acquisitions outside India, in accordance with the authority a

Clarification of News : The media had reports on January 05, 2006 that Dishman Pharmaceuticals and Chemicals Limited is planning to set up a greenfield project at China's Shanghai Chemical Park. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Dishman Pharmaceuticals and Chemicals Limited has vide its letter inter-alia stated, "We would like to clarify that the planning of project in China is in preliminary stage an

Clarification of News : The media had reports that Dishman Pharmaceuticals and Chemicals Limited is planning to set up a greenfield project at China's Shanghai Chemical Park. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Reply is awaited from Dishman Pharmaceuticals and Chemicals Limited.